Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705438
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Unrelated Donor Hematopoietic Stem Cell Transplantation for Treatment of Non-Malignant Genetic Diseases Using a Myeloablative Reduced Toxicity Conditioning Regimen

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Prognostic Relevance of DNMT3A R882 Mutations in AML Patients Undergoing Non-Myeloablative Conditioning Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2018English

Evaluation of Chimerism Dynamics After Allogeneic Hematopoietic Stem Cell Transplantation in Children With Non-Malignant Diseases.

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Non-Myeloablative Conditioning With Allogeneic Hematopoietic Cell Transplantation for the Treatment of High-Risk Acute Lymphoblastic Leukemia

Haematologica
Hematology
2011English

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma: A Nationwide Survey in Japan

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients With Non-Malignant Diseases: Preliminary Results of a Phase II Study

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy